Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pacira Biosciences Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
PCRX
Nasdaq
2834
https://www.pacira.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pacira Biosciences Inc
Earnings Miss: Pacira BioSciences, Inc. Missed EPS By 17% And Analysts Are Revising Their Forecasts
- May 10th, 2024 11:44 am
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
- May 10th, 2024 11:00 am
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
- May 8th, 2024 8:05 pm
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
- May 8th, 2024 3:35 pm
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript
- May 8th, 2024 1:33 pm
Pacira BioSciences Inc (PCRX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ...
- May 8th, 2024 7:47 am
Pacira BioSciences Reports Q1 2024 Results: Aligns with EPS Projections and Announces $150 ...
- May 7th, 2024 10:03 pm
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
- May 7th, 2024 8:00 pm
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
- May 7th, 2024 12:00 pm
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
- Apr 30th, 2024 12:00 pm
Pacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trend
- Apr 11th, 2024 12:37 pm
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
- Apr 4th, 2024 3:33 pm
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 12:00 pm
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
- Mar 14th, 2024 12:23 pm
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
- Mar 13th, 2024 11:00 am
Director Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX)
- Mar 9th, 2024 4:55 am
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
- Mar 6th, 2024 1:00 pm
11 Best Small Cap Pharma Stocks to Invest In
- Mar 5th, 2024 1:28 am
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcript
- Mar 1st, 2024 1:38 pm
Pacira BioSciences Full Year 2023 Earnings: EPS Beats Expectations
- Mar 1st, 2024 1:13 pm
Scroll